Capstone Wealth Management Group (Pennsylvania)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$540K Buy
450
+7
+2% +$7.15K 0.19% 62
2026
Q1
$407K Hold
443
– – 0.17% 70
2025
Q4
$476K Hold
443
– – 0.2% 57
2025
Q3
$338K Buy
443
+51
+13% +$38K 0.14% 60
2025
Q2
$306K Hold
392
– – 0.29% 44
2025
Q1
$324K Sell
392
-30
-7% -$25K 0.18% 59
2024
Q4
$326K Sell
422
-34
-7% -$28.2K 0.17% 65
2024
Q3
$404K Hold
456
– – 0.24% 58
2024
Q2
$413K Buy
456
+2
+0.4% +$1.6K 0.27% 57
2024
Q1
$353K Buy
454
+5
+1% +$3.56K 0.25% 59
2023
Q4
$262K Buy
449
+70
+18% +$40.9K 0.25% 54
2023
Q3
$204K Buy
+379
New +$195K 0.21% 55

Other funds holding LLY

Capstone Wealth Management Group (Pennsylvania)'s LLY Position: Q2 2026 in Review

Capstone Wealth Management Group (Pennsylvania) increased its Eli Lilly (LLY) stake by 1.6% in Q2 2026, buying an estimated $7.15K and bringing the position to 450 shares worth $540K. The position accounts for 0.19% of the portfolio, ranked #62.

Capstone Wealth Management Group (Pennsylvania) first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Capstone Wealth Management Group (Pennsylvania) held 450 shares of Eli Lilly worth $540K as of Q2 2026.
  • Capstone Wealth Management Group (Pennsylvania) bought 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
  • Eli Lilly made up 0.19% of Capstone Wealth Management Group (Pennsylvania)'s portfolio in Q2 2026, its #62 holding.
  • Capstone Wealth Management Group (Pennsylvania) first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capstone Wealth Management Group (Pennsylvania)'s 13F filing for Q2 2026, filed 30 Jul 2026.